Distribution of HeLa cells (%) in different phases of the cell cycle treated with tested compounds (concentrations corresponding to IC50 and 2IC50) at 24 h and 48 h of treatment.
Cell cycle phase | Sub-G1 | G1 | S | G2/M |
---|---|---|---|---|
Treatment for 24 h | ||||
CONTROL | 0.48 | 61.29 | 13.85 | 22.77 |
D (IC50) | 0.72 | 53.69 | 16.01 | 28.11 |
D (2IC50) | 0.86 | 49.63 | 15.58 | 31.73 |
F (IC50) | 0.87 | 50.91 | 16.24 | 32.34 |
F (2IC50) | 0.96 | 51.77 | 15.58 | 32.16 |
Treatment for 48 h | ||||
CONTROL | 2.05 | 65.40 | 11.58 | 21.31 |
D (IC50) | 2.17 | 55.28 | 13.90 | 29.22 |
D (2IC50) | 2.31 | 53.03 | 15.03 | 30.11 |
F (IC50) | 2.08 | 50.44 | 12.93 | 35.03 |
F (2IC50) | 3.70 | 43.34 | 15.06 | 38.32 |